Imbalance in treatment discontinuation without progression between experimental and control arms among randomized trials in advanced breast cancer.

Authors

Faris Tamimi

Faris Tamimi

Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada

Faris Tamimi , Abhenil Mittal , Consolacion Molto , Diego Malon Gimenez , Michelle B. Nadler , Eitan Amir

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Other Breast Cancer Subtypes

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 1110)

DOI

10.1200/JCO.2023.41.16_suppl.1110

Abstract #

1110

Poster Bd #

331

Abstract Disclosures